PAGSEG Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? PAGSEG Inc trades at $10.65 (market cap $2.90B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Relay Therapeutics Inc. Common Stock is the larger of the two by market cap, and PAGSEG Inc pays a 10.66% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold PAGSEG Inc for 26 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| PAGS | RLAY | |
|---|---|---|
Market Cap | $2.90B | $3.94B |
Volume | 4,931,855 | 3,432,928 |
Sector | Industrials | Health |
52-Week High | $12.00 | $20.75 |
52-Week Low | $8.44 | $6.03 |
Typical Hold Time | 26 Days | 0 Days |
Enterprise Value | $11.04B | $3.06B |
Dividend Yield | 10.66% | — |
Signals from Pluang's Aura AI — not financial advice
PAGS trades at $10.51, down 1.96% on the day, with a bullish technical signal from moving averages. The stock shows strong fundamentals with a P/E of 7 and net income margin of 10.45%, supported by recent earnings beats. A dividend of $0.28 is scheduled for September 2026. Analyst consensus is bullish with a $10.70 price target, though RSI levels indicate potential overbought conditions near-term.
The outlook for PAGS is positive given its undervalued metrics and profitability, but risks include macroeconomic pressures in Brazil and elevated credit losses. Institutional interest remains strong, with recent buys from Bank of America. The stock presents a value opportunity with dividend income, though investors should monitor earnings consistency and interest rate impacts.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →